Literature DB >> 16712963

Bovine herpesvirus 4 based vector interaction with liver cells in vitro and in vivo.

Gaetano Donofrio1, Eugenio Martignani, Enzo Poli, Claudia Lange, Filippo Maria Martini, Sandro Cavirani, Clotilde Silvia Cabassi, Simone Taddei, Cesidio Filippo Flammini.   

Abstract

Gene transfer into hepatocytes is highly desirable for the long-term goal of replacing deficient proteins and correcting metabolic disorders. Bovine herpesvirus 4 (BoHV-4) based vector capability to transduce rat liver cells in vitro and in vivo was assessed. For the in vitro study, a buffalo rat liver cell line was successfully transduced by BoHV-4 and although did not show toxicity, the immediate early two viral gene was transcribed and cells harboring the intact viral genome could be pharmacologically selected, but no viral replication took place. For the in vivo study, adult male rats were inoculated intraportally and intraparenchimally with a BoHV-4 expressing enhanced green fluorescent protein and liver sections were analyzed through fluorescent microscopy. Although the liver parenchyma could not be transduced, the endothelial layer of the liver vasculature showed a robust transgene expression without toxicity. Successful BoHV-4 based vector transduction of primary cultures of rat hepatocytes suggests that extrinsic factors, and not hepatocytes per se, are the cause of such lack of transducibility. The present study serves as a starting point for study of the use of BoHV-4 based vectors to target gene delivery to vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712963     DOI: 10.1016/j.jviromet.2006.04.008

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  In vivo image analysis of BoHV-4-based vector in mice.

Authors:  Valentina Franceschi; Fabio Franco Stellari; Carlo Mangia; Sarah Jacca; Sophia Lavrentiadou; Sandro Cavirani; Mathias Heikenwalder; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

2.  Generation and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studies.

Authors:  Valentina Franceschi; Sarah Jacca; Elena L Sassu; Fabio F Stellari; Vicky L van Santen; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

3.  BoHV-4-based vector delivering Ebola virus surface glycoprotein.

Authors:  Alfonso Rosamilia; Sarah Jacca; Giulia Tebaldi; Silvia Tiberti; Valentina Franceschi; Francesca Macchi; Sandro Cavirani; Gary Kobinger; Donald P Knowles; Gaetano Donofrio
Journal:  J Transl Med       Date:  2016-11-24       Impact factor: 5.531

4.  BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.

Authors:  Valentina Franceschi; Scott Parker; Sarah Jacca; Ryan W Crump; Konstantin Doronin; Edguardo Hembrador; Daniela Pompilio; Giulia Tebaldi; Ryan D Estep; Scott W Wong; Mark R Buller; Gaetano Donofrio
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

5.  Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer.

Authors:  Sarah Jacca; Valeria Rolih; Elena Quaglino; Valentina Franceschi; Giulia Tebaldi; Elisabetta Bolli; Alfonso Rosamilia; Simone Ottonello; Federica Cavallo; Gaetano Donofrio
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

6.  Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

Authors:  Andrea Elizabeth Verna; Valentina Franceschi; Giulia Tebaldi; Francesca Macchi; Valentina Menozzi; Claudia Pastori; Lucia Lopalco; Simone Ottonello; Sandro Cavirani; Gaetano Donofrio
Journal:  Front Immunol       Date:  2017-10-25       Impact factor: 7.561

7.  Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses.

Authors:  Francesca Macchi; José Manuel Rojas; Andrea Elizabeth Verna; Noemí Sevilla; Valentina Franceschi; Giulia Tebaldi; Sandro Cavirani; Verónica Martín; Gaetano Donofrio
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.